News
ORGO
1.790
+1.70%
0.030
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
NASDAQ · 3d ago
Truist Financial Sticks to Its Hold Rating for Organogenesis Holdings (ORGO)
TipRanks · 3d ago
Weekly Report: what happened at ORGO last week (0803-0807)?
Weekly Report · 6d ago
Organogenesis Earnings Call Highlights Turnaround Challenges
TipRanks · 08/08 00:07
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/07 17:05
Organogenesis Shares Plunge After Revenue Slump, Wider Loss and Lower Outlook
Dow Jones · 08/07 16:24
Organogenesis price target lowered to $2 from $3 at Truist
TipRanks · 08/07 14:20
Organogenesis Holdings Is Maintained at Hold by Truist Securities
Dow Jones · 08/07 13:34
Organogenesis Holdings Price Target Cut to $2.00/Share From $3.00 by Truist Securities
Dow Jones · 08/07 13:34
Truist Securities Maintains Hold on Organogenesis Holdings, Lowers Price Target to $2
Benzinga · 08/07 13:24
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 08/07 12:05
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 08/07 12:02
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Astrana Health (ASTH), Hyperfine (HYPR) and Organogenesis Holdings (ORGO)
TipRanks · 08/07 12:01
At a glance: stocks gapping down premarket
Seeking Alpha · 08/07 11:37
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/07 08:33
Organogenesis Launches New $75 Million At-The-Market Offering
TipRanks · 08/06 21:52
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 08/06 21:06
Organogenesis Holdings GAAP EPS of -$0.77 misses by $0.42, revenue of $42.8M misses by $11.45M
Seeking Alpha · 08/06 20:18
*Organogenesis Holdings 2Q Loss $96.3M >ORGO
Dow Jones · 08/06 20:05
Press Release: Organogenesis Holdings Inc. -2-
Dow Jones · 08/06 20:05
More
Webull provides a variety of real-time ORGO stock news. You can receive the latest news about Organogenesis Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About ORGO
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.